X

Trial Profile

Drug Elution and DIstal Protection During Percutaneous CoronAry Intervention in sT Elevation Myocardial InfarctiON. Acronym: DEDICATION.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel; Sirolimus; Zotarolimus
Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
Focus Therapeutic Use
Acronyms DEDICATION

Most Recent Events

14 Mar 2010 Three-year results, of drug-eluting stents versus bare stents, have been presented as a late-breaking abstract at the 59th Annual Scientific Session of the American College of Cardiology (ACC 2010).
23 Sep 2009 Biomarkers information updated
09 Sep 2008 Eight-month results, of drug-eluting stents versus bare stents, have been published in Circulation.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com